Case report: further delineation of AEBP1-related Ehlers–Danlos Syndrome (classical-like EDS type 2) in an additional patient and comprehensive clinical and molecular review of the literature

The Ehlers–Danlos Syndromes (EDS), a group of hereditary connective tissue disorders, were classified into 13 subtypes in the 2017 International Classification. Recently, a new subtype of EDS called classical-like EDS type 2 (clEDS2), which is caused by biallelic variants in the adipocyte enhancer b...

Full description

Bibliographic Details
Main Authors: Tomomi Yamaguchi, Shujiro Hayashi, So Nagai, Akihiko Uchiyama, Sei-Ichiro Motegi, Tomomi Fujikawa, Yuri Takiguchi, Tomoki Kosho
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Genetics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2023.1102101/full
_version_ 1797832953940672512
author Tomomi Yamaguchi
Tomomi Yamaguchi
Tomomi Yamaguchi
Shujiro Hayashi
So Nagai
So Nagai
Akihiko Uchiyama
Sei-Ichiro Motegi
Tomomi Fujikawa
Yuri Takiguchi
Tomoki Kosho
Tomoki Kosho
Tomoki Kosho
Tomoki Kosho
author_facet Tomomi Yamaguchi
Tomomi Yamaguchi
Tomomi Yamaguchi
Shujiro Hayashi
So Nagai
So Nagai
Akihiko Uchiyama
Sei-Ichiro Motegi
Tomomi Fujikawa
Yuri Takiguchi
Tomoki Kosho
Tomoki Kosho
Tomoki Kosho
Tomoki Kosho
author_sort Tomomi Yamaguchi
collection DOAJ
description The Ehlers–Danlos Syndromes (EDS), a group of hereditary connective tissue disorders, were classified into 13 subtypes in the 2017 International Classification. Recently, a new subtype of EDS called classical-like EDS type 2 (clEDS2), which is caused by biallelic variants in the adipocyte enhancer binding protein 1 (AEBP1) gene, was identified. We describe the 11th patient (9th family) with clEDS2, who was complicated by a critical vascular event (superior mesenteric artery aneurysm and rupture). A next-generation sequencing panel-based analysis revealed compound heterozygous variants in AEBP1: NM_001129.5:c.[2296G>T]; [2383dup], p.[(Glu766*)]; [(Glu795Glyfs*3)]. Light microscopic analyses showed increased interfibrillar spaces in the reticular dermis, a disorganized arrangement of collagen fibers, and decreased collagen content. An electron microscopic analysis showed the presence of collagen fibrils with irregular contours (flower-like appearance) and small collagen fibrils. A biochemical analysis showed reduced secretion of type I and type III procollagen. Clinical and molecular features of the current patient and all previously reported patients were reviewed comprehensively. Manifestations noted in most cases (>80%) included skin features (hyperextensibility, atrophic scars, easy bruising, excessive skin/skin folding, delayed wound healing, translucency, piezogenic papules), skeletal features (generalized joint hypermobility, dislocations/subluxations, pes planus), dental abnormalities, and neuromuscular abnormalities. Critical complications, each occurring in a single case, included superior mesenteric artery multiple aneurysm and rupture, aortic root dilation requiring surgery, and bowel rupture. Most AEBP1 variants were predicted or experimentally confirmed to lead to nonsense-mediated mRNA decay, whereas one variant resulted in a protein that was retained intracellularly and not secreted. Clinical, molecular, pathological, and biochemical features of the current patient, as well as a review of all previously reported patients, suggest the importance of the aortic carboxypeptidase-like protein encoded by AEBP1 in collagen fibrillogenesis.
first_indexed 2024-04-09T14:15:58Z
format Article
id doaj.art-1ff3241ae08b4512bdc48ea0b65d6820
institution Directory Open Access Journal
issn 1664-8021
language English
last_indexed 2024-04-09T14:15:58Z
publishDate 2023-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Genetics
spelling doaj.art-1ff3241ae08b4512bdc48ea0b65d68202023-05-05T08:46:47ZengFrontiers Media S.A.Frontiers in Genetics1664-80212023-05-011410.3389/fgene.2023.11021011102101Case report: further delineation of AEBP1-related Ehlers–Danlos Syndrome (classical-like EDS type 2) in an additional patient and comprehensive clinical and molecular review of the literatureTomomi Yamaguchi0Tomomi Yamaguchi1Tomomi Yamaguchi2Shujiro Hayashi3So Nagai4So Nagai5Akihiko Uchiyama6Sei-Ichiro Motegi7Tomomi Fujikawa8Yuri Takiguchi9Tomoki Kosho10Tomoki Kosho11Tomoki Kosho12Tomoki Kosho13Center for Medical Genetics, Shinshu University Hospital, Matsumoto, JapanDepartment of Medical Genetics, Shinshu University School of Medicine, Matsumoto, JapanDivision of Clinical Sequencing, Shinshu University School of Medicine, Matsumoto, JapanDepartment of Dermatology, Dokkyo Medical University, Mibu, JapanCenter for Medical Genetics, Shinshu University Hospital, Matsumoto, JapanProblem-Solving Oriented Training Program for Advanced Medical Personnel: NGSD (Next-Generation Super Doctor) Project, Matsumoto, JapanDepartment of Dermatology, Gunma University Graduate School of Medicine, Maebashi, JapanDepartment of Dermatology, Gunma University Graduate School of Medicine, Maebashi, JapanDivision of Clinical Sequencing, Shinshu University School of Medicine, Matsumoto, JapanDivision of Clinical Sequencing, Shinshu University School of Medicine, Matsumoto, JapanCenter for Medical Genetics, Shinshu University Hospital, Matsumoto, JapanDepartment of Medical Genetics, Shinshu University School of Medicine, Matsumoto, JapanDivision of Clinical Sequencing, Shinshu University School of Medicine, Matsumoto, JapanResearch Center for Supports to Advanced Science, Shinshu University, Matsumoto, JapanThe Ehlers–Danlos Syndromes (EDS), a group of hereditary connective tissue disorders, were classified into 13 subtypes in the 2017 International Classification. Recently, a new subtype of EDS called classical-like EDS type 2 (clEDS2), which is caused by biallelic variants in the adipocyte enhancer binding protein 1 (AEBP1) gene, was identified. We describe the 11th patient (9th family) with clEDS2, who was complicated by a critical vascular event (superior mesenteric artery aneurysm and rupture). A next-generation sequencing panel-based analysis revealed compound heterozygous variants in AEBP1: NM_001129.5:c.[2296G>T]; [2383dup], p.[(Glu766*)]; [(Glu795Glyfs*3)]. Light microscopic analyses showed increased interfibrillar spaces in the reticular dermis, a disorganized arrangement of collagen fibers, and decreased collagen content. An electron microscopic analysis showed the presence of collagen fibrils with irregular contours (flower-like appearance) and small collagen fibrils. A biochemical analysis showed reduced secretion of type I and type III procollagen. Clinical and molecular features of the current patient and all previously reported patients were reviewed comprehensively. Manifestations noted in most cases (>80%) included skin features (hyperextensibility, atrophic scars, easy bruising, excessive skin/skin folding, delayed wound healing, translucency, piezogenic papules), skeletal features (generalized joint hypermobility, dislocations/subluxations, pes planus), dental abnormalities, and neuromuscular abnormalities. Critical complications, each occurring in a single case, included superior mesenteric artery multiple aneurysm and rupture, aortic root dilation requiring surgery, and bowel rupture. Most AEBP1 variants were predicted or experimentally confirmed to lead to nonsense-mediated mRNA decay, whereas one variant resulted in a protein that was retained intracellularly and not secreted. Clinical, molecular, pathological, and biochemical features of the current patient, as well as a review of all previously reported patients, suggest the importance of the aortic carboxypeptidase-like protein encoded by AEBP1 in collagen fibrillogenesis.https://www.frontiersin.org/articles/10.3389/fgene.2023.1102101/fullEhlers-Danlos Syndromeclassical-like EDS type 2 (clEDS2)adipocyte enhancer binding protein 1 (AEBP1)aortic carboxypeptidase-like protein (ACLP)autosomal recessiveconnective tissue disorders
spellingShingle Tomomi Yamaguchi
Tomomi Yamaguchi
Tomomi Yamaguchi
Shujiro Hayashi
So Nagai
So Nagai
Akihiko Uchiyama
Sei-Ichiro Motegi
Tomomi Fujikawa
Yuri Takiguchi
Tomoki Kosho
Tomoki Kosho
Tomoki Kosho
Tomoki Kosho
Case report: further delineation of AEBP1-related Ehlers–Danlos Syndrome (classical-like EDS type 2) in an additional patient and comprehensive clinical and molecular review of the literature
Frontiers in Genetics
Ehlers-Danlos Syndrome
classical-like EDS type 2 (clEDS2)
adipocyte enhancer binding protein 1 (AEBP1)
aortic carboxypeptidase-like protein (ACLP)
autosomal recessive
connective tissue disorders
title Case report: further delineation of AEBP1-related Ehlers–Danlos Syndrome (classical-like EDS type 2) in an additional patient and comprehensive clinical and molecular review of the literature
title_full Case report: further delineation of AEBP1-related Ehlers–Danlos Syndrome (classical-like EDS type 2) in an additional patient and comprehensive clinical and molecular review of the literature
title_fullStr Case report: further delineation of AEBP1-related Ehlers–Danlos Syndrome (classical-like EDS type 2) in an additional patient and comprehensive clinical and molecular review of the literature
title_full_unstemmed Case report: further delineation of AEBP1-related Ehlers–Danlos Syndrome (classical-like EDS type 2) in an additional patient and comprehensive clinical and molecular review of the literature
title_short Case report: further delineation of AEBP1-related Ehlers–Danlos Syndrome (classical-like EDS type 2) in an additional patient and comprehensive clinical and molecular review of the literature
title_sort case report further delineation of aebp1 related ehlers danlos syndrome classical like eds type 2 in an additional patient and comprehensive clinical and molecular review of the literature
topic Ehlers-Danlos Syndrome
classical-like EDS type 2 (clEDS2)
adipocyte enhancer binding protein 1 (AEBP1)
aortic carboxypeptidase-like protein (ACLP)
autosomal recessive
connective tissue disorders
url https://www.frontiersin.org/articles/10.3389/fgene.2023.1102101/full
work_keys_str_mv AT tomomiyamaguchi casereportfurtherdelineationofaebp1relatedehlersdanlossyndromeclassicallikeedstype2inanadditionalpatientandcomprehensiveclinicalandmolecularreviewoftheliterature
AT tomomiyamaguchi casereportfurtherdelineationofaebp1relatedehlersdanlossyndromeclassicallikeedstype2inanadditionalpatientandcomprehensiveclinicalandmolecularreviewoftheliterature
AT tomomiyamaguchi casereportfurtherdelineationofaebp1relatedehlersdanlossyndromeclassicallikeedstype2inanadditionalpatientandcomprehensiveclinicalandmolecularreviewoftheliterature
AT shujirohayashi casereportfurtherdelineationofaebp1relatedehlersdanlossyndromeclassicallikeedstype2inanadditionalpatientandcomprehensiveclinicalandmolecularreviewoftheliterature
AT sonagai casereportfurtherdelineationofaebp1relatedehlersdanlossyndromeclassicallikeedstype2inanadditionalpatientandcomprehensiveclinicalandmolecularreviewoftheliterature
AT sonagai casereportfurtherdelineationofaebp1relatedehlersdanlossyndromeclassicallikeedstype2inanadditionalpatientandcomprehensiveclinicalandmolecularreviewoftheliterature
AT akihikouchiyama casereportfurtherdelineationofaebp1relatedehlersdanlossyndromeclassicallikeedstype2inanadditionalpatientandcomprehensiveclinicalandmolecularreviewoftheliterature
AT seiichiromotegi casereportfurtherdelineationofaebp1relatedehlersdanlossyndromeclassicallikeedstype2inanadditionalpatientandcomprehensiveclinicalandmolecularreviewoftheliterature
AT tomomifujikawa casereportfurtherdelineationofaebp1relatedehlersdanlossyndromeclassicallikeedstype2inanadditionalpatientandcomprehensiveclinicalandmolecularreviewoftheliterature
AT yuritakiguchi casereportfurtherdelineationofaebp1relatedehlersdanlossyndromeclassicallikeedstype2inanadditionalpatientandcomprehensiveclinicalandmolecularreviewoftheliterature
AT tomokikosho casereportfurtherdelineationofaebp1relatedehlersdanlossyndromeclassicallikeedstype2inanadditionalpatientandcomprehensiveclinicalandmolecularreviewoftheliterature
AT tomokikosho casereportfurtherdelineationofaebp1relatedehlersdanlossyndromeclassicallikeedstype2inanadditionalpatientandcomprehensiveclinicalandmolecularreviewoftheliterature
AT tomokikosho casereportfurtherdelineationofaebp1relatedehlersdanlossyndromeclassicallikeedstype2inanadditionalpatientandcomprehensiveclinicalandmolecularreviewoftheliterature
AT tomokikosho casereportfurtherdelineationofaebp1relatedehlersdanlossyndromeclassicallikeedstype2inanadditionalpatientandcomprehensiveclinicalandmolecularreviewoftheliterature